FDA Orders Amgen to Cease Misleading Vectibix Promotions
The FDA ordered Amgen to stop misleading Vectibix promotional communications. The company faces seizure and injunction if violations are not corrected.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.